In a preclinical study, UC Davis Comprehensive Cancer Center scientists have developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, ...

Treatment introduces an expansion of the scope of gene therapies that might lead to similar treatments for neurodegenerative ...

A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase III IMforte ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...

Researchers in the lab of Hans-Peter Kiem, MD, PhD, at Fred Hutch Cancer Center have devised a method that could one day treat genetic hematologic disorders by correcting how the body makes blood ...

According to the DataM Intelligence, The global cancer gene therapy market size was valued as US$ 3.97 billion in 2024 and is expected to reach US$ 19.97 billion by 2033, growing at a CAGR of 19.8% ...

Researchers have developed a new lipid for delivering mRNA that is safer and more effective than current technologies. By changing the chemistry of one key ingredient in lipid nanoparticles (LNPs), ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Scientists from Tel Aviv University and Boston Children's Hospital use a optimized virus to deliver a corrected gene into the ...